Olumiant 4 mg film-coated tablets clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of Baricitinib as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects with New-Onset Polymyalgia Rheumatica (JAK-SPARE 1)
This study is looking at a new treatment called Olumiant for polymyalgia rheumatica. It aims to see if Olumiant can help people get better and reduce their need for steroid medications, which often have side effects. Researchers are checking how well it works and if it's safe.
For: polymyalgia rheumaticaAustria · Czechia · Italy - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis (JAKUVEITE)
This study is looking at a new tablet treatment called baricitinib (Olumiant) for a type of eye inflammation called uveitis. Researchers want to see if it can help improve symptoms and reduce the need for other medications over six months.
For: Active non-anterior non-infectious uveitisFrance - AuthorisedTherapeutic exploratory (Phase II)
BOOSTERS - BiOlogics in FOlliculitis decalvanS : an adaptaTivE tRial reSearch
This study looks at new treatments for folliculitis decalvans, a skin condition causing hair loss and scalp sores. Researchers are testing different medicines to see if they can reduce the severity of the condition and improve how people feel, aiming for clearer skin and less discomfort.
For: Folliculitis decalvansFrance